Search Results 171-180 of 17516 for Assay
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early- ...
Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...
The performance characteristics of the ddPCR assay for the detection of ctDNA mutation in uveal melanoma patients will be assessed by comparing the mutation ...
Learn about the blood urea nitrogen (BUN) test to assess kidney function and what possible results could mean.
Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...
Also, to remove and quantify unattached sulfated glycosaminoglycans on implant surfaces using specific biochemical assay, to assess the surface morphology ...
Challenges for complement functional assays in the clinical laboratory: From test validation to clinical interpretation. ... Assay. Clin Chem 2019 Oct; 65 (10): ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.